Sollano-Sancho I, Rubio-Cebrian B, de la Cruz ML, et al. Successful treatment of interstitial pneumonitis with anakinra in a patient with adult-onset still’s disease. Eur J Hosp Pharm Sci Pract. 2021;28(6):346–9. https://doi.org/10.1136/ejhpharm-2020-002377.

Article  Google Scholar 

Swanson C, Khan EK, Cooper A, et al. Pediatric systemic juvenile idiopathic arthritis-related lung disease: description of clinical cohort and review of management. Pediatr Pulmonol. 2024;59(3):724–33. https://doi.org/10.1002/ppul.26821.

Article  PubMed  Google Scholar 

Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult still’s disease. J Rheumatol. 1992;19(3):424–30.

CAS  PubMed  Google Scholar 

Giancane G, Consolaro A, Lanni S, Davi S, Schiappapietra B, Ravelli A. Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther. 2016;3(2):187–207. https://doi.org/10.1007/s40744-016-0040-4.

Article  PubMed  PubMed Central  Google Scholar 

Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767–78. https://doi.org/10.1016/s0140-6736(07)60363-8.

Article  CAS  PubMed  Google Scholar 

Fautrel B, Mitrovic S, De Matteis A et al. EULAR / PreS Recommendations for the Diagnosis and Management of Systemic Juvenile Idiopathic Arthritis (sJIA) and Adult Onset Still’s Disease (AOSD) [Abstract]. American College of Rheumatology. 2023. 75 (suppl. 9): sp. Available in: https://acrabstracts.org/abstract/eular-pres-recommendations-for-the-diagnosis-and-management-of-systemic-juvenile-idiopathic-arthritis-sjia-and-adult-onset-stills-disease-aosd/. Accessed 10 June 2024.

Al-Mayouf SM, Al Mutairi M, Bouayed K, et al. Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East. Pediatr Rheumatol Online J. 2021;19:166. https://doi.org/10.1186/s12969-021-00650-x.

Article  PubMed  PubMed Central  Google Scholar 

Thierry S, Fautrel B, Lemelle I, Guillemin F. Prevalence and incidence of juvenile idiopathic arthritis: a systematic review. Joint Bone Spine. 2024;81(2):112–7. https://doi.org/10.1016/j.jbspin.2013.07.007.

Article  CAS  Google Scholar 

McHugh J. Global prevalence of JIA, JSLE and club foot. Nat Rev Rheumatol. 2020;16(8):408. https://doi.org/10.1038/s41584-020-0465-6.

Article  PubMed  Google Scholar 

Zhang G, Liu W, Zhang X, et al. Rescued from desperation: adult-onset still’s disease with life-threatening interstitial lung disease and macrophage activation: successful treatment by Tocilizumab. Z Rheumatol. 2022;81(4):335–8. https://doi.org/10.1007/s00393-021-01063-7.

Article  PubMed  Google Scholar 

Magadur-Joly G, Billaud E, Barrier JH, et al. Epidemiology of adult still’s disease: estimate of the incidence by a retrospective study in West France. Ann Rheum Dis. 1995;54(7):587–90. https://doi.org/10.1136/ard.54.7.587.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wallimann M, Bouayed K, Cannizzaro E, et al. Disease evolution in systemic juvenile idiopathic arthritis: an international, observational cohort study through cohort. Pediatr Rheumatol Online J. 2023;21(1):96. https://doi.org/10.1186/s12969-023-00886-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lamnle B, Schroder E, Steiger U. Systemische Juvenile Chronische Arthritis (M.Still) bei Erwachsenen. Ubersicht die Literatur. Schweiz Med Wochenschr. 1983;113:126–37.

Google Scholar 

Yoo D. Biologics for the treatment of adult-onset still’s disease. Expert Opin Biol Ther. 2019;19(11):1173–90. https://doi.org/10.1080/14712598.2019.1652591.

Article  CAS  PubMed  Google Scholar 

Sukharomana M, Udomittipong K, Ruangchira-Urai R, et al. Nonspecific interstitial pneumonia in refractory systemic juvenile idiopathic arthritis responded to tocilizumab treatment. Asian Pac J Allergy Immunol. 2022;40(2):173–7. https://doi.org/10.12932/AP-050819-0616.

Article  Google Scholar 

Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset still’s disease. J Autoimmun. 2018;93:24–36. https://doi.org/10.1016/j.jaut.2018.07.018.

Article  PubMed  Google Scholar 

Appenzeller S, Castro GW, Costallat LT, Samara AM, Bértolo MB. Doença De still do Adulto: Diagnóstico E Evolução. Rev Bras Reumatol. 2003;43(6):352–7.

Article  Google Scholar 

Lee JJY, Schneider R. Systemic juvenile idiopathic arthritis. Pediatr Clin North Am. 2018;65(4):691–709. https://doi.org/10.1016/j.pcl.2018.04.005.

Article  PubMed  Google Scholar 

Buckley MM, Rabinovich CE. Pulmonary manifestations of rheumatic diseases in children. Pediatr Clin North Am. 2021;68(1):147–66. https://doi.org/10.1016/j.pcl.2020.09.005.

Article  PubMed  Google Scholar 

Richardson AE, Warrier K, Vyas H. Respiratory complications of rheumatological diseases in childhood. Arch Dis Child. 2016;101(8):752–8. https://doi.org/10.1136/archdischild-2014-306049.

Article  PubMed  Google Scholar 

Rood JE, Rezk A, Pogoriler J, et al. Improvement of refractory systemic juvenile idiopathic arthritis-associated lung disease with single-agent blockade of IL-1β and IL-18. J Clin Immunol. 2023;43(1):101–8. https://doi.org/10.1007/s10875-022-01353-y.

Article  CAS  PubMed  Google Scholar 

Arlet JB, Le TH, Marinho A, Amoura Z, Wechsler B, Papo T, Piette JC. Reactive hemophagocytic syndrome in adult-onset still’s disease: a report of six patients and a review of the literature. Ann RheumDis. 2006;65(12):1596–601. https://doi.org/10.1136/ard.2005.046904.

Article  Google Scholar 

Ruscitti P, Cantarini L, Nigrovic PA, et al. Recent advances and evolving concepts in still’s disease. Nat Rev Rheumatol. 2024;20:116–32. https://doi.org/10.1038/s41584-023-01065-6.

Article  PubMed  Google Scholar 

Takakuwa Y, Hanaoka H, Kiyokawa T, et al. Adult-onset still’s disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse. Clin Exp Rheumatol. 2019;Supp 121(6):23–7.

Google Scholar 

Erkens R, Esteban Y, Towe C, et al. Pathogenesis and treatment of refractory disease courses in systemic juvenile idiopathic arthritis: refractory arthritis, recurrent macrophage activation syndrome and chronic lung disease. Rheum Dis Clin North Am. 2021;47(4):585–606. https://doi.org/10.1016/j.rdc.2021.06.003.

Article  PubMed  Google Scholar 

Vega-Fernandez P, Ting TV, Mar DA, et al. Lung ultrasound in children with systemic juvenile idiopathic arthritis-associated interstitial lung disease. Arthritis Care Res (Hoboken). 2023;75(5):983–8. https://doi.org/10.1002/acr.24957.

Article  PubMed  Google Scholar 

Song G, Bae SC, Lee YH. Diagnostic accuracy of lung ultrasound for interstitial lung disease in patients with connective tissue diseases: a meta-analysis. Clin Exp Rheumatol. 2016;34(1):11–6.

PubMed  Google Scholar 

Canna SW, Schulert GS, de Jesu A et al. Proceedings from the 2nd NextGen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3–4, 2019. Pediatr Rheumatol Online J, 2020. 18 (Supp. 1): 53–68. https://doi.org/10.1186/s12969-020-00444-7

Leavis HL, van Daele PLA, Mulders-Manders C, et al. Management of adult-onset still’s disease: evidence- and consensus-based recommendations by experts. Rheumatology. 2024;63(6):1656–63. https://doi.org/10.1093/rheumatology/kead461.

Article  PubMed  Google Scholar 

Ben Tekaya A, Hannech E, Saidane O, et al. Adult-onset and juvenile-onset still’s disease: a comparative study of both sides. Curr Rheumatol Rev. 2023;19(2):235–41. https://doi.org/10.2174/1573397118666220617101447.

Article  Google Scholar 

Ruscitti P, Natoli V, Consolaro A, et al. Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset still’s disease. Rheumatology (Oxford). 2022;61(10):4124–9. https://doi.org/10.1093/rheumatology/keac027.

Article  PubMed  Google Scholar 

PRISMA. PRISMA 2020 Checklist [Internet]. 2024. Available from: https://www.prisma-statement.org/prisma-2020-checklist [Access in September 20, 2024].

National Heart, Lung, and Blood Institute. Study quality assessment tools [Internet]. 2024. Bethesda: National Institutes of Health; 2021. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. [Access in September 20, 2024].

Brazil. National Health Council. Resolution No. 510, of April 7, 2016 [Internet]. Brasília: National Health Council. 2016. Available from: https://www.gov.br/conselho-nacional-de-saude/pt-br/acesso-a-informacao/legislacao/resolucoes/2016/resolucao-no-510.pdf/view. [Access in September 30, 2024].

Bader-Meunier B, Hadchouel A, Berteloot L, et al. Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease: a case report. Ann Rheum Dis. 2022;81(2):e20–1. https://doi.org/10.1136/annrheumdis-2020-216983.

Article  PubMed  Google Scholar 

Clarke SLN, Robertson L, Rice GI, et al. Type 1 interferonopathy presenting as juvenile idiopathic arthritis with interstitial lung disease: report of a new phenotype. Pediatr Rheumatol Online J. 2020;18(1):37. https://doi.org/10.1186/s12969-020-00425-w.

Article